Is remote lung sound monitoring after COPD exacerbation feasible?

In an observational study that began enrollment last month, researchers will determine if continuous, remote lung sound monitoring via an FDA-cleared wearable is feasible in adults with COPD, according to a press release.
The enrollment target for the SL-RS-SHORE study involving the RESP Biosensor (Strados Labs) is 20 adults with COPD who had a recent exacerbation. The release noted that adherence, compliance and retention as they relate to the wearable will be measured at 90 days after hospital discharge or after exacerbation outpatient follow-up.
In addition to feasibility, researchers plan
